Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 93, Issue 6, 2008, Pages

  El Khuffash, Afif ^a   Barry, D ^a   Walsh, K ^b   Davis, P G ^c   Molloy, E J ^a,b  

^a NATIONAL MATERNITY HOSPITAL   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^c ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T;

ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HIGH RISK INFANT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BIRTH WEIGHT; CEREBRAL HEMORRHAGE; DUCTUS ARTERIOSUS, PATENT; EPIDEMIOLOGIC METHODS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; TROPONIN T;

EID: 55349093311     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2007.133140     Document Type: Article

References (40)

1. Brooks JM, Travadi JN, Patole SK, et al. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 2005;90:F235-9.
2. Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate 2006;89:330-5.
3. El-Khuffash A, Higgins M, Walsh K, et al. Quantitative assessment of the degree of ductal steal using celiac artery blood flow to left ventricular output ratio in preterm infants. Neonatology 2007;93:206-12.
4. Evans N. Current controversies in the diagnosis and treatment of patent ductus arteriosus in preterm infants. Adv Neonatal Care 2003;3:168-77.
5. Knight DB. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 2001;6:63-73.
6. Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006;CD004213.
7. Schmidt B, Davis P, Moddemann D, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001;344:1966-72.
8. Apak I, Iltumur K, Tamam Y, et al. Serum cardiac troponin T levels as an indicator of myocardial injury in ischemic and hemorrhagic stroke patients. Tohoku J Exp Med 2005;205:93-101.
9. Hays A, Diringer MN. Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage. Neurology 2006;66:1330-4.
10. Costa S, Zecca E, De RG, et al. Is serum troponin T a useful marker of myocardial damage in newborn infants with perinatal asphyxia? Acta Paediatr 2007;96:181-4.
11. Clark SJ, Newland P, Yoxall CW, et al. Sequential cardiac troponin T following delivery and its relationship with myocardial performance in neonates with respiratory distress syndrome. Eur J Pediatr 2006;165:87-93.
12. El-Khuffash A, Molloy EJ. Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates? Arch Dis Child Fetal Neonatal Ed 2007;92:F320-4.
13. Flynn PA, da Graca RL, Auld PA, et al. The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr 2005;147:38-42.
14. El-Khuffash AF, Amoruso M, Culliton M, et al. N-terminal pro-B-type natriuretic peptide as a marker of ductal haemodynamic significance in preterm infants: a prospective observational study. Arch Dis Child Fetal Neonatal Ed 2007;92:F421-2.
15. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 2006;92:843-9.
16. Moss TJ. Respiratory consequences of preterm birth. Clin Exp Pharmacol Physiol 2006;33:280-4.
17. Papile LA, Burstein J, Burstein R, et al. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.
18. Mueller T, Gegenhuber A, Poelz W, et al. Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease. Clin Chem 2003;49:976-9.
19. El Hajjar M, Vaksmann G, Rakza T, et al. Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 2005;90:F419-22.
20. Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995;127:774-9,
21. Evans N, Kluckow M. Early determinants of right and left ventricular output in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996;74:F88-94.
22. Alverson DC, Eldridge MW, Johnson JD, et al. Noninvasive measurement of cardiac output in healthy preterm and term newborn infants. Am J Perinatol 1984;1:148-51.
23. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol 2006;26:S14-18.
24. Clyman RI, Chorne N. Patent ductus arteriosus: evidence for and against treatment. J Pediatr 2007;150:216-19.
25. Clark SJ, Newland P, Yoxall CW, et al. Concentrations of cardiac troponin T in neonates with and without respiratory distress. Arch Dis Child Fetal Neonatal Ed 2004;89:F348-52.
26. Clark SJ, Newland P, Yoxall CW, et al. Cardiac troponin T in cord blood. Arch Dis Child Fetal Neonatal Ed 2001;84:F34-7.
27. Bakker J, Gies I, Slavenburg B, et al. Reference values for N-terminal pro-B-type natriuretic peptide in umbilical cord blood. Clin Chem 2004;50:2465.
28. Bar-Oz B, Lev-Sagie A, Arad I, et al. N-terminal pro-B-type natriuretic peptide concentrations in mothers just before delivery, in cord blood, and in newborns. Clin Chem 2005;51:926-7.
29. Hammerer-Lercher A, Mair J, Tews G, et al. N-terminal pro-B-type natriuretic peptide concentrations are markedly higher in the umbilical cord blood of newborns than in their mothers. Clin Chem 2005;51:913-15.
30. McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed 2007;92:F424-7.
31. Trevisanuto D, Zaninotto M, Lachin M, et al. Effect of patent ductus arteriosus and indomethacin treatment on serum cardiac troponin T levels in preterm infants with respiratory distress syndrome. Eur J Pediatr 2000;159:273-6.
32. Etgen T, Baum H, Sander K, et al. Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis. Stroke 2005;36:270-5.
33. Iltumur K, Yavavli A, Apak I, et al. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke. Am Heart J 2006;151:1115-22.
34. Hays A, Diringer MN. Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage. Neurology 2006;66:1330-4.
35. Jensen JK, Kristensen SR, Bak S, et al. Frequency and significance of troponin T elevation in acute ischemic stroke. Am J Cardiol 2007;99:108-12.
36. Myers MG, Norris JW, Hachniski VC, et al. Plasma norepinephrine in stroke. Stroke 1981;12:200-4.
37. Roland EH, Hill A. Germinal matrix-intraventricular hemorrhage in the premature newborn: management and outcome. Neurol Clin 2003;21:833-51.
38. Gagliardi L, Cavazza A, Brunelli A, et al. Assessing mortality risk in very low birthweight infants: a comparison of CRIB, CRIB-II, and SNAPPE-II. Arch Dis Child Fetal Neonatal Ed 2004;89:F419-22.
39. Clark SJ, Newland P, Yoxall CW, et al. Sequential cardiac troponin T following delivery and its relationship with myocardial performance in neonates with respiratory distress syndrome. Eur J Pediatr 2006;165:87-93.
40. Clark SJ, Newland P, Yoxall CW, et al. Sequential cardiac troponin T following delivery and its relationship with myocardial performance in neonates with respiratory distress syndrome. Eur J Pediatr 2006;165:87-93.